Related Experiment Video
Updated: May 20, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Targeted therapies for metastatic melanoma
Sunandana Chandra1, Anna C Pavlick
1NYU School of Medicine, New York, NY 10016, USA.
Dermatologic Clinics
|July 18, 2012
Summary
Novel therapeutics, when combined, may establish a new standard for advanced melanoma treatment. Future research into signaling pathways and drug actions could enable personalized medicine and improve patient survival.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Advanced melanoma presents significant treatment challenges.
- Current therapeutic strategies have limitations in improving long-term survival.
Purpose of the Study:
- To review novel therapeutics for advanced melanoma.
- To explore the potential of combination therapies.
- To discuss the future of personalized treatment approaches.
Main Methods:
- Literature review of novel therapeutic agents.
- Analysis of drug mechanisms of action.
- Discussion of oncogenic signaling pathways in melanoma.
Main Results:
- Combination therapies show promise for a new standard of care.
- Understanding signaling pathways is key to treatment selection.
- Individualized treatment strategies are emerging.
Conclusions:
- Thoughtful combinations of novel therapeutics may define future melanoma treatment.
- Personalized medicine based on molecular profiling will improve outcomes.
- Advancements in understanding tumor biology will enhance survival rates.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.